Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the united states, 2002-2008

Pediatric Infectious Disease Journal

Volumn 28, Issue 12, 2009, Pages 1069-1072

  Tseng, Hung Fu ^a   Smith, Ning ^a   Marcy, Stephan Michael ^a,b   Sy, Lina S ^a   Jacobsen, Steven J ^a  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Herpes zoster; Incidence; Varicella vaccine; Varicella zoster virus

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; ASTHMA; DEVELOPMENTAL DISORDER; DRUG ABUSE; HEALTH INSURANCE; HERPES ZOSTER; INCIDENCE; LYMPHATIC LEUKEMIA; MEDICAL RECORD; MENTAL DISEASE; PRIORITY JOURNAL; UNITED STATES; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION; VIRUS STRAIN;

EID: 74049139455     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181acf84f     Document Type: Article

References (30)

1. Vazquez M, Shapiro ED. Varicella vaccine and infection with varicella-zoster virus. N Engl J Med. 2005;352:439-440.
2. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996;45(RR-11):1-36.
3. White CJ. Clinical trials of varicella vaccine in healthy children. Infect Dis Clin North Am. 1996;10:595-608.
4. Black S, Shinefield H, Ray P, et al. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatr Infect Dis J. 1999;18:1041-1046.
5. Gershon AA. Varicella vaccine: rare serious problems-but the benefits still outweigh the risks. J Infect Dis. 2003;188:945-947.
6. Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis. 2008;197(suppl 2):S165-S169.
7. Sharrar RG, LaRussa P, Galea SA, et al. The postmarketing safety profile of varicella vaccine. Vaccine. 2000;19:916-923.
8. Hardy I, Gershon AA, Steinberg SP, et al; Varicella Vaccine Collaborative Study Group. The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia. N Engl J Med. 1991;325:1545-1550.
9. Takayama N, Takayama M, Takita J. Herpes zoster in healthy children immunized with varicella vaccine. Pediatr Infect Dis J. 2000;19:169-170.
10. Levin MJ, DeBiasi RL, Bostik V, et al. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis. 2008;198:1444-1447.
11. Obieta MP, Jacinto SS. Herpes zoster after varicella vaccination in a healthy young child. Int J Dermatol. 2008;47:640-641.
12. Ota K, Kim V, Lavi S, et al. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old. Pediatr Infect Dis J. 2008;27:847-848.
13. Iyer S, Mittal MK, Hodinka RL. Herpes Zoster and Meningitis Resulting From Reactivation of Varicella Vaccine Virus in an Immunocompetent Child. Ann Emerg Med. 2009;53:792-795.
14. Guess HA, Broughton DD, Melton LJ III, et al. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics. 1985;76:512-517.
15. Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med. 1995;155:1605-1609.
16. Petursson G, Helgason S, Gudmundsson S, et al. Herpes zoster in children and adolescents. Pediatr Infect Dis J. 1998;17:905-908.
17. Chidiac C, Bruxelle J, Daures JP, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis. 2001;33:62-69.
18. Marin M, Guris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40.
19. White CJ. Varicella-zoster virus vaccine. Clin Infect Dis. 1997;24:753-761.
20. Chen JJ, Zhu Z, Gershon AA, et al. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell. 2004;119:915-926.
21. Baba K, Yabuuchi H, Takahashi M, et al. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study. J Pediatr. 1986;108:372-377.
22. Wurzel CL, Kahan J, Heitler M, et al. Prognosis of herpes zoster in healthy children. Am J Dis Child. 1986;140:477-478.
23. David TJ, Williams ML. Herpes zoster in infancy. Scand J Infect Dis. 1979;11:185-186.
24. Terada K, Kawano S, Yoshihiro K, et al. Characteristics of herpes zoster in otherwise normal children. Pediatr Infect Dis J. 1993;12:960-961.
25. Wu CT, Tsai SC, Lin JJ, et al. Disseminated varicella infection in a child receiving short-term steroids for asthma. Pediatr Dermatol. 2008;25:484-486.
26. Irwin MR, Olmstead R, Oxman MN. Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi. J Am Geriatr Soc. 2007;55:511-517.
27. Grose C, Bonthius D, Afifi AK. Chickenpox and the geniculate ganglion: facial nerve palsy, Ramsay Hunt syndrome and acyclovir treatment. Pediatr Infect Dis J. 2002;21:615-617.
28. Schmader K, Studenski S, MacMillan J, et al. Are stressful life events risk factors for herpes zoster? J Am Geriatr Soc. 1990;38:1188-1194.
29. Levin MJ, Rinaldo CR Jr, Leary PL, et al. Immune response to herpes virus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis. 1979;140:851-857.
30. Thomas SL, Wheeler JG, Hall AJ. Case-control study of the effect of mechanical trauma on the risk of herpes zoster. BMJ. 2004;328:439.